Immunological characterization of human umbilical cord lining derived cells and their therapeutic application in a diabetic mouse model

IMMUNOLOGICAL CHARACTERIZATION OF HUMAN UMBILICAL CORD LINING DERIVED CELLS AND THEIR THERAPEUTIC APPLICATION IN A DIABETIC MOUSE MODEL ZHOU YUE A THESIS SUBMITTED FOR THE DEGREE OF DOCTOR OF PHILOSOPHY DEPARTMENT OF MEDICINE NATIONAL UNIVERSITY OF SINGAPORE 2010   i   ii ACKNOWLEDGMENTS The work of this thesis has been done in several laboratories, with the support of many people. I feel lucky to have known and worked with these people and I would like to express my gratitude here. First of all, I owe my deepest gratitude to my supervisors and advisors who have constantly guided, supported and encouraged me: Professor K O Lee, Doctor Paul A. MacAry, Assoc Professor Phan Toan Thang, Doctor Gan Shu Uin and Professor Roy Calne. Prof. Lee has taught me the scientific way of thinking and more importantly, has always inspired me to see science with interest and curiosity, which was my major motivation through these years of research. I am also grateful for the invaluable time he has spent to read and edit this thesis. Dr. MacAry, though not officially my supervisor, has led the immunological studies, which contributed to a large part of this thesis. Prof. Phan generously supplied the cord lining cells for all the experiments of this research project and guided me when I started with animal experiments. Dr. Gan performed all the lentiviral transduction for the cells used in this project and also read and edited this thesis. She has been more than a supervisor but also a caring friend. Prof. Calne has provided invaluable advice on my project every time he visited Singapore. I am also indebted to all the fellow students and colleagues that I have worked with on this thesis project. It is impossible to name them all here. But I feel especially grateful to Lin Gen who worked with me on the immunological experiments and also spent his time going through the first few drafts of this thesis. I benefited a lot from working with Phua Meow Ling, Cindy on the diabetic mouse model and from discussion with Dr. Laura Rivino. I would also like to thank other people from immunology program, including Lim Yan Ting, Fatimah Bte Mustafa, Too Chien Tei and Desmond Chan. Co  iii workers from Prof. Phan’s lab, especially Audery, Khoo Ying Ting and Dr. Anandaroope Mukhopadhyay, taught me the basic molecular biology techniques, and Jeyakumar Masilamani did the primary isolation and culture for cord lining cells together with Prof. Phan. Co-workers from Dr. Gan Shu Uin’s lab, including Diane, Tan Ai Lin, Ngo Kae Siang, Ooi Shu Qin and Fu Zhen Ying, gave me precious mental support during my difficult times and shared with me some of the happiest moments in these past years. Ngo Kae Siang and Fu Zhen Ying also helped me with the animal experiments. In addition, I have received technical assistance from people from adjacent laboratories: Han Hwan Chour helped me troubleshoot the immunohistochemistry experiments. Pradeep Paul Panengad did cryosection for my cord lining cell graft. It was great pleasure to have spent my research years with these people because they were not only supportive at work but also pleasant to spend time with. Finally, I want to thank my mother who has brought me to this world and shaped me as what I am. It was her who planted in my mind the idea of being a scientist and led me all the way to fulfill this goal up to this day.   iv TABLE OF CONTENTS TITLE PAGE …………………………………………………………………….…… .i ACKNOWLEDGMENTS………………………………………………………….… .iii TABLE OF CONTENTS………………………………………………………….…….v SUMMARY…………………………………………………………………………….xiii LIST OF FIGURES AND TABLES………………………….……………………… xv LIST OF PUBLICATION AND PRESENTATIONS…………………………… xix LIST OF ABBREVIATIONS…………………………………………………………xxi CHAPTER 1.1 1.2 Introduction………………………………………………………1 Background………………………………………………………….…………….1 1.1.1 Prevalence of diabetes mellitus……………………………………………1 1.1.2 Pancreas and islet transplantation……………………………………… 1.1.3 Cell therapy……………………………………………………………… 1.1.4 Gene therapy………………………………………………………………5 1.1.5 Immunosuppression……………………………………………………….5 Present study………………………………………………………………………6 CHAPTER Literature Review……………………………………………… 2.1 Embryonic stem cells…………………………………… ……………………….9 2.2 Induced pluripotent stem cells………………………………………………… .13 2.3 Bone marrow derived mesenchymal stem cells………………………………….14 2.3.1   MHC expression…………………………………………………………16 v 2.4 2.3.2 T lymphocytes……………………………………………………………16 2.3.3 Dendritic cells………………………………………………………… 18 2.3.4 B lymphocytes and natural killer cells………………………………….19 Fetal/neonatal stem cells…………………………………………………………20 2.4.1 Background………………………………………………………………20 2.4.1.1 Immune tolerance in pregnancy………………………………….21 2.4.1.2 HLA-G in immune tolerance…………………………………….23 2.4.1.2.1 HLA-G receptors……………………………………………… .23 2.4.1.2.2 HLA-G functions……………………………………………… .24 2.4.1.2.3 In vivo evidence of HLA-G function…………………………….27 2.4.1.3 HLA-E……………………………………………………………28 2.4.1.4 Pregnancy related tissues in cell therapy……………………… .28 2.4.2 Amniotic fluid stem cells……………………………………………… .29 2.4.3 Placental stem cells………………………………………………………34 2.4.3.1 Amniotic epithelial cells…………………………………………35 2.4.3.2 Amniotic mesenchymal cells…………………………………….37 2.4.4 Umbilical cord blood stem cells…………………………………………39 2.4.5 Wharton’s jelly stromal cells…………………………………………….40 2.4.6 Umbilical cord perivascular cells……………………………………… .44 2.4.7 Umbilical cord lining cells……………………………………………….45 CHAPTER 3.1 Materials…………………………………………………………………………49 3.1.1   Materials and Methods…………………………………………49 Primary cells and cell lines………………………………………………49 vi 3.2 3.1.1.1 Cord lining epithelial and mesenchymal cells………………… .49 3.1.1.2 Choriocarcinoma cell lines………………………………………52 3.1.1.3 Primary keratinocytes……………………………………………52 3.1.1.4 Conditioned culture supernatants……………………………… .52 3.1.2 PCR primers…………………………………………………………… .53 3.1.3 Gene transfer constructs………………………………………………….55 3.1.3.1 Gene expression………………………………………………….55 3.1.3.2 Gene silencing……………………………………………………55 3.1.5 Animals………………………………………………………………… 56 3.1.6 Antibodies and kits………………………………………………………57 Methods………………………………………………………………………… 58 3.2.1 Colony formation and rhodamine staining………………………………58 3.2.2 Molecular biology techniques……………………………………………58 3.2.2.1 Protein extraction and quantification…………………………….58 3.2.2.2 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS- PAGE)………………………………………………………………………………… 59 3.2.2.3 Western blot…………………………………………………… .60 3.2.2.4 Reverse transcription-polymerase chain reaction (RT-PCR)……60 3.2.2.5 Agarose gel electrophoresis…………………………………… .61 3.2.3 Flow cytometry………………………………………………………… 62 3.2.4 Isolation of the immune cell populations……………………………… .63 3.2.4.1 Density gradient centrifugation………………………………… 63 3.2.4.2 Magnetic-activated cell sorting (MACS)……………………… .64 3.2.5   Stimulated T cell proliferation………………………………………… .64 vii 3.2.5.1 Mitogen stimulation assay…………………………………… .64 3.2.5.2 Mixed leukocyte reaction (MLR)…………………………….64 3.2.5.2.1 MLR in 96-well plate setting…………………………………….65 3.2.5.2.2 MLR in 24-well plate setting…………………………………….65 3.2.5.2.3 CLEC titration experiments…………………………………… .66 3.2.6 [3H] thymidine incorporation assay…………………………………… .66 3.2.7 CFSE cell proliferation assay…………………………………………….66 3.2.8 Multiplex cytokine assay……………………………………………… .68 3.2.9 Stable transduction using lentivial constructs……………………………69 3.2.10 In vivo studies……………………………………………………………69 3.2.10.1 Xenotransplantation for survival study………………………… 69 3.2.10.2 CLEC-based ex vivo gene therapy………………………………70 3.2.10.3 Anesthesia, euthanasia and necropsy…………………………….71 3.2.11 In vitro differentiation toward insulin-producing cells………………… 71 3.2.12 Immunohistochemistry………………………………………………… 72 3.2.12.1 Paraffin sections………………………………… .…………… 72 3.2.12.2 Cytospin………………………………………………………….72 3.2.13 Microscopy………………………………………………………………73 3.2.14 Statistical analysis……………………………………………………….73 CHAPTER In Vitro Studies of Cord Lining Cells………………………….75 4.1 Introduction………………………………………………………………………75 4.2 Results………………………………………………………………………… 76 4.2.1   Morphology and growth properties of cord lining cells……………… 76 viii 4.3 4.2.2 HLA-G and HLA-E protein expression in CLECs………………………78 4.2.3 HLA-G splicing variants expressed in CLECs………………………… 80 4.2.4 HLA-G and HLA-E protein expression in CLMCs…………………… .82 4.2.5 Epithelial and MHC class I markers in CLECs………………………….84 Summary……………………………………………………………………… 86 CHAPTER In Vitro Analysis of Cord Lining Cell Immunogenicity……87 5.1 Introduction…………………………………………………………………… 87 5.2 Results……………………………………………………………………………88 5.2.1 Mitogen stimulated T cell proliferation………………………………….88 5.2.2 Mixed leukocyte reactions (MLR)……………………………………….90 5.2.2.1 Conditioned medium…………………………………………… 90 5.2.2.2 CD4+ versus CD8+ T cells……………………………………….92 5.2.2.3 Co-culture……………………………………………………… 94 5.2.3 T cell apoptosis…………………………………………………………102 5.2.4 CD4+CD25highFoxp3+ regulatory T cells……………………………….104 5.2.5 Other regulatory T cells…………………………… ………………….106 5.2.6 Cytokine profile of MLR……………………………………………….110 5.2.7 HLA-G functional studies…………………………………………… .116 5.2.7.1 shRNA inhibition……………………………………………….116 5.2.7.2 Blocking antibody………………………………………………118 5.2.8 5.3   LPS induced dendritic cell maturation………………………………….120 Summary……………………………………………………………………… 122 ix CHAPTER Xenotransplantation of Cord Lining Cells………………… 125 6.1 Introduction…………………………………………………………………… 125 6.2 Results………………………………………………………………………… 126 6.3 6.2.1 Composition of the cellular graft……………………………………….126 6.2.2 Detection of CLECs after xenotransplantation…………………………128 6.2.3 Neovascularization of CLEC graft…………………………………… .130 6.2.4 Control primary keratinocytes………………………………………….132 6.2.5 Prolonged survival of CLECs in contrast to keratinocytes…………… 134 6.2.6 Re-culturing of CLECs from graft…………………………………… .136 6.2.7 CLEC and keratinocyte co-transplantation…………………………… 138 6.2.8 Detection of CLMCs after xenotransplantation……………………… .140 Summary……………………………………………………………………… 144 CHAPTER Ex Vivo Insulin Gene Therapy using CLECs……………… 145 7.1 Introduction…………………………………………………………………… 145 7.2 Results………………………………………………………………………… 146   7.2.1 In vitro differentiation toward insulin-producing cells…………………146 7.2.2 Transgene expression in vitro………………………………………… 148 7.2.3 Localization of CLEC graft………………………….…………………152 7.2.4 eGFP expression in vivo……………………………………………… 156 7.2.5 Histology of engrafted CLEC cluster……………………………… .158 7.2.6 Serum glucose levels and body weights of recipient mice…………… 162 7.2.7 Histology of mouse pancreas………………………………………… .164 7.2.8 Insulin staining………………………………………………………….168 x Grinnemo KH, Kumagai-Braesch M, Mansson-Broberg A, Skottman H, Hao X, Siddiqui A, Andersson A, Stromberg AM, Lahesmaa R, Hovatta O, Sylven C, Corbascio M and Dellgren G (2006). "Human embryonic stem cells are immunogenic in allogeneic and xenogeneic settings." Reprod Biomed Online 13(5): 712-24. Groskreutz DJ, Sliwkowski MX and Gorman CM (1994). "Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin." J Biol Chem 269(8): 6241-5. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE and Roncarolo MG (1997). "A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis." Nature 389(6652): 737-42. Hammer A, Hutter H, Blaschitz A, Mahnert W, Hartmann M, Uchanska-Ziegler B, Ziegler A and Dohr G (1997). "Amnion epithelial cells, in contrast to trophoblast cells, express all classical HLA class I molecules together with HLA-G." Am J Reprod Immunol 37(2): 161-71. Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B, Thyssen S, Gray DA and Bhatia M (2003). "Bone marrow-derived stem cells initiate pancreatic regeneration." Nat Biotechnol 21(7): 763-70. Hirshberg B, Rother KI, Digon BJ, 3rd, Lee J, Gaglia JL, Hines K, Read EJ, Chang R, Wood BJ and Harlan DM (2003). "Benefits and risks of solitary islet transplantation for type diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience." Diabetes Care 26(12): 3288-95. Hoehn H, Bryant EM, Karp LE and Martin GM (1974). "Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. I. Clonal morphology and growth potential." Pediatr Res 8(8): 746-54. Hong S, Kang UJ, Isacson O and Kim KS (2008). "Neural precursors derived from human embryonic stem cells maintain long-term proliferation without losing the potential to differentiate into all three neural lineages, including dopaminergic neurons." J Neurochem 104(2): 316-24. Hori S, Nomura T and Sakaguchi S (2003). "Control of regulatory T cell development by the transcription factor Foxp3." Science 299(5609): 1057-61. Hows JM, Bradley BA, Marsh JC, Luft T, Coutinho L, Testa NG and Dexter TM (1992). "Growth of human umbilical-cord blood in longterm haemopoietic cultures." Lancet 340(8811): 73-6. Hviid TV, Moller C, Sorensen S and Morling N (1998). "Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast." Hum Immunol 59(2): 87-98. Ianus A, Holz GG, Theise ND and Hussain MA (2003). "In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion." J Clin Invest 111(6): 843-50. 187 Ibrahim EC, Guerra N, Lacombe MJ, Angevin E, Chouaib S, Carosella ED, Caignard A and Paul P (2001). "Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma." Cancer Res 61(18): 6838-45. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M and Manuelpillai U (2007). "Stem cells derived from human fetal membranes display multilineage differentiation potential." Biol Reprod 77(3): 577-88. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, Fibbe WE and Kanhai HH (2004). "Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta." Stem Cells 22(7): 1338-45. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, Noort WA, Claas FH, Willemze R, Fibbe WE and Kanhai HH (2003). "Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation." Blood 102(4): 1548-9. Iop L, Chiavegato A, Callegari A, Bollini S, Piccoli M, Pozzobon M, Rossi CA, Calamelli S, Chiavegato D, Gerosa G, De Coppi P and Sartore S (2008). "Different cardiovascular potential of adult- and fetal-type mesenchymal stem cells in a rat model of heart cryoinjury." Cell Transplant 17(6): 679-94. Itskovitz-Eldor J, Schuldiner M, Karsenti D, Eden A, Yanuka O, Amit M, Soreq H and Benvenisty N (2000). "Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers." Mol Med 6(2): 88-95. Janossy G and Greaves MF (1971). "Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens." Clin Exp Immunol 9(4): 483-98. Ji JF, He BP, Dheen ST and Tay SS (2004). "Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury." Stem Cells 22(3): 415-27. Jiang W, Shi Y, Zhao D, Chen S, Yong J, Zhang J, Qing T, Sun X, Zhang P, Ding M, Li D and Deng H (2007). "In vitro derivation of functional insulin-producing cells from human embryonic stem cells." Cell Res 17(4): 333-44. Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD and Mao N (2005). "Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells." Blood 105(10): 4120-6. Jonuleit H and Schmitt E (2003). "The regulatory T cell family: distinct subsets and their interrelations." J Immunol 171(12): 6323-7. Kakishita K, Nakao N, Sakuragawa N and Itakura T (2003). "Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6hydroxydopamine lesions." Brain Res 980(1): 48-56. Kappel LW, Goldberg GL, King CG, Suh DY, Smith OM, Ligh C, Holland AM, Grubin J, Mark NM, Liu C, Iwakura Y, Heller G and van den Brink MR (2009). "IL-17 contributes to CD4-mediated graft-versus-host disease." Blood 113(4): 945-52. 188 Karahuseyinoglu S, Cinar O, Kilic E, Kara F, Akay GG, Demiralp DO, Tukun A, Uckan D and Can A (2007). "Biology of stem cells in human umbilical cord stroma: in situ and in vitro surveys." Stem Cells 25(2): 319-31. Karlmark KR, Freilinger A, Marton E, Rosner M, Lubec G and Hengstschlager M (2005). "Activation of ectopic Oct-4 and Rex-1 promoters in human amniotic fluid cells." Int J Mol Med 16(6): 987-92. Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M, Gepstein A, Livne E, Binah O, Itskovitz-Eldor J and Gepstein L (2001). "Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes." J Clin Invest 108(3): 407-14. Khan WS, Adesida AB, Tew SR, Lowe ET and Hardingham TE (2010). "Bone marrow-derived mesenchymal stem cells express the pericyte marker 3G5 in culture and show enhanced chondrogenesis in hypoxic conditions." J Orthop Res 28(6): 834-40. Kita K, Gauglitz GG, Phan TT, Herndon DN and Jeschke MG (2010). "Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane." Stem Cells Dev 19(4): 491-502. Klimanskaya I, Chung Y, Becker S, Lu SJ and Lanza R (2006). "Human embryonic stem cell lines derived from single blastomeres." Nature 444(7118): 481-5. Klimanskaya I, Chung Y, Meisner L, Johnson J, West MD and Lanza R (2005). "Human embryonic stem cells derived without feeder cells." Lancet 365(9471): 1636-41. Klyushnenkova E, Mosca JD, Zernetkina V, Majumdar MK, Beggs KJ, Simonetti DW, Deans RJ and McIntosh KR (2005). "T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression." J Biomed Sci 12(1): 47-57. Knight SC, Bedford PA and Stagg AJ (2005). "Mixed Leukocyte Reactions." Meauring Immunity Chapter 30(ISBN 0-12-455900-X): London. Academic Press. Knudtzon S (1974). "In vitro growth of granulocytic colonies from circulating cells in human cord blood." Blood 43(3): 357-61. Koch CA, Geraldes P and Platt JL (2008). "Immunosuppression by embryonic stem cells." Stem Cells 26(1): 89-98. Kogler G, Sensken S, Airey JA, Trapp T, Muschen M, Feldhahn N, Liedtke S, Sorg RV, Fischer J, Rosenbaum C, Greschat S, Knipper A, Bender J, Degistirici O, Gao J, Caplan AI, Colletti EJ, Almeida-Porada G, Muller HW, Zanjani E and Wernet P (2004). "A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential." J Exp Med 200(2): 123-35. Koh SH, Kim KS, Choi MR, Jung KH, Park KS, Chai YG, Roh W, Hwang SJ, Ko HJ, Huh YM, Kim HT and Kim SH (2008). "Implantation of human umbilical cord-derived mesenchymal stem cells as a neuroprotective therapy for ischemic stroke in rats." Brain Res 1229: 233-48. 189 Kohn DB, Weinberg KI, Nolta JA, Heiss LN, Lenarsky C, Crooks GM, Hanley ME, Annett G, Brooks JS, el-Khoureiy A and et al. (1995). "Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency." Nat Med 1(10): 1017-23. Kolambkar YM, Peister A, Soker S, Atala A and Guldberg RE (2007). "Chondrogenic differentiation of amniotic fluid-derived stem cells." J Mol Histol 38(5): 405-13. Kopen GC, Prockop DJ and Phinney DG (1999). "Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains." Proc Natl Acad Sci U S A 96(19): 10711-6. Kosuga M, Sasaki K, Tanabe A, Li XK, Okawa H, Ogino I, Okuda O, Arai H, Sakuragawa N, Kamata Y, Azuma N, Suzuki S, Yamada M and Okuyama T (2001). "Engraftment of genetically engineered amniotic epithelial cells corrects lysosomal storage in multiple areas of the brain in mucopolysaccharidosis type VII mice." Mol Ther 3(2): 139-48. Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, Santarlasci V, Mazzinghi B, Pizzolo G, Vinante F, Romagnani P, Maggi E, Romagnani S and Annunziato F (2006). "Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells." Stem Cells 24(2): 386-98. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E and Dazzi F (2003). "Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T cells to their cognate peptide." Blood 101(9): 3722-9. Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, Young H, Richardson M, Smart NG, Cunningham J, Agulnick AD, D'Amour KA, Carpenter MK and Baetge EE (2008). "Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo." Nat Biotechnol 26(4): 443-52. Kubo M, Sonoda Y, Muramatsu R and Usui M (2001). "Immunogenicity of human amniotic membrane in experimental xenotransplantation." Invest Ophthalmol Vis Sci 42(7): 153946. La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, Lo Iacono M, Di Stefano A, Giannuzzi P, Marasa L, Cappello F, Zummo G and Farina F (2009). "Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers." Histochem Cell Biol 131(2): 26782. Le Blanc K (2006). "Mesenchymal stromal cells: Tissue repair and immune modulation." Cytotherapy 8(6): 559-61. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M and Ringden O (2004). "Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells." Lancet 363(9419): 1439-41. Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, Arvidson J, Ljungman P, Lonnies H, Nava S and Ringden O (2007). "Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells." Leukemia 21(8): 1733-8. 190 Le Blanc K, Tammik C, Rosendahl K, Zetterberg E and Ringden O (2003). "HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells." Exp Hematol 31(10): 890-6. Le Bouteiller P and Solier C (2001). "Is antigen presentation the primary function of HLA-G?" Microbes Infect 3(4): 323-32. Le Friec G, Laupeze B, Fardel O, Sebti Y, Pangault C, Guilloux V, Beauplet A, Fauchet R and Amiot L (2003). "Soluble HLA-G inhibits human dendritic cell-triggered allogeneic Tcell proliferation without altering dendritic differentiation and maturation processes." Hum Immunol 64(8): 752-61. Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J, Guillet JG, Carosella ED and Rouas-Freiss N (1999). "HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes." Int Immunol 11(8): 1351-6. Le Maux A, Noel G, Birebent B, Grosset JM, Vu N, De Guibert S, Bernard M, Semana G and Amiot L (2008). "Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells." Clin Exp Immunol 152(1): 50-6. Le Rond S, Azema C, Krawice-Radanne I, Durrbach A, Guettier C, Carosella ED and RouasFreiss N (2006). "Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive/ regulatory T cells." J Immunol 176(5): 326676. Lechner A, Yang YG, Blacken RA, Wang L, Nolan AL and Habener JF (2004). "No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo." Diabetes 53(3): 616-23. Lee KD, Kuo TK, Whang-Peng J, Chung YF, Lin CT, Chou SH, Chen JR, Chen YP and Lee OK (2004). "In vitro hepatic differentiation of human mesenchymal stem cells." Hepatology 40(6): 1275-84. Lee N, Goodlett DR, Ishitani A, Marquardt H and Geraghty DE (1998a). "HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences." J Immunol 160(10): 4951-60. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M and Geraghty DE (1998b). "HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A." Proc Natl Acad Sci U S A 95(9): 5199-204. Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD and Prockop DJ (2006). "Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice." Proc Natl Acad Sci U S A 103(46): 1743843. LeMaoult J, Krawice-Radanne I, Dausset J and Carosella ED (2004). "HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells." Proc Natl Acad Sci U S A 101(18): 7064-9. 191 LeMaoult J, Zafaranloo K, Le Danff C and Carosella ED (2005). "HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells." Faseb J 19(6): 662-4. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J and Langer R (2002). "Endothelial cells derived from human embryonic stem cells." Proc Natl Acad Sci U S A 99(7): 4391-6. Li H, Niederkorn JY, Neelam S, Mayhew E, Word RA, McCulley JP and Alizadeh H (2005). "Immunosuppressive factors secreted by human amniotic epithelial cells." Invest Ophthalmol Vis Sci 46(3): 900-7. Li L, Baroja ML, Majumdar A, Chadwick K, Rouleau A, Gallacher L, Ferber I, Lebkowski J, Martin T, Madrenas J and Bhatia M (2004). "Human embryonic stem cells possess immune-privileged properties." Stem Cells 22(4): 448-56. Lila N, Amrein C, Guillemain R, Chevalier P, Latremouille C, Fabiani JN, Dausset J, Carosella ED and Carpentier A (2002). "Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection." Circulation 105(16): 1949-54. Lindahl-Kiessling K and Book JA (1964). "Effects of Phytohaemagglutinin on Leucocytes." Lancet 2(7359): 591. Lu L, Xiao M, Shen RN, Grigsby S and Broxmeyer HE (1993). "Enrichment, characterization, and responsiveness of single primitive CD34 human umbilical cord blood hematopoietic progenitors with high proliferative and replating potential." Blood 81(1): 41-8. Magatti M, De Munari S, Vertua E, Gibelli L, Wengler GS and Parolini O (2008). "Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities." Stem Cells 26(1): 182-92. Magatti M, De Munari S, Vertua E, Nassauto C, Albertini A, Wengler GS and Parolini O (2009). "Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes." Cell Transplant 18(8): 899-914. Manuelpillai U, Tchongue J, Lourensz D, Vaghjiani V, Samuel CS, Liu A, Williams ED and Sievert W (2010). "Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl-treated mice." Cell Transplant 19(9): 1157-68. Mareschi K, Biasin E, Piacibello W, Aglietta M, Madon E and Fagioli F (2001). "Isolation of human mesenchymal stem cells: bone marrow versus umbilical cord blood." Haematologica 86(10): 1099-100. Martin GR (1981). "Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells." Proc Natl Acad Sci U S A 78(12): 7634-8. Maynard CL and Weaver CT (2008). "Diversity in the contribution of interleukin-10 to T-cellmediated immune regulation." Immunol Rev 226: 219-33. 192 Meisel R, Zibert A, Laryea M, Gobel U, Daubener W and Dilloo D (2004). "Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenasemediated tryptophan degradation." Blood 103(12): 4619-21. Menard C, Hagege AA, Agbulut O, Barro M, Morichetti MC, Brasselet C, Bel A, Messas E, Bissery A, Bruneval P, Desnos M, Puceat M and Menasche P (2005). "Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study." Lancet 366(9490): 1005-12. Menier C, Saez B, Horejsi V, Martinozzi S, Krawice-Radanne I, Bruel S, Le Danff C, Reboul M, Hilgert I, Rabreau M, Larrad ML, Pla M, Carosella ED and Rouas-Freiss N (2003). "Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules." Hum Immunol 64(3): 315-26. Meyerrose TE, De Ugarte DA, Hofling AA, Herrbrich PE, Cordonnier TD, Shultz LD, Eagon JC, Wirthlin L, Sands MS, Hedrick MA and Nolta JA (2007). "In vivo distribution of human adipose-derived mesenchymal stem cells in novel xenotransplantation models." Stem Cells 25(1): 220-7. Miki T, Lehmann T, Cai H, Stolz DB and Strom SC (2005). "Stem cell characteristics of amniotic epithelial cells." Stem Cells 23(10): 1549-59. Miki T, Mitamura K, Ross MA, Stolz DB and Strom SC (2007). "Identification of stem cell marker-positive cells by immunofluorescence in term human amnion." J Reprod Immunol 75(2): 91-6. Min JY, Sullivan MF, Yang Y, Zhang JP, Converso KL, Morgan JP and Xiao YF (2002). "Significant improvement of heart function by cotransplantation of human mesenchymal stem cells and fetal cardiomyocytes in postinfarcted pigs." Ann Thorac Surg 74(5): 156875. Moreau P, Mouillot G, Rousseau P, Marcou C, Dausset J and Carosella ED (2003). "HLA-G gene repression is reversed by demethylation." Proc Natl Acad Sci U S A 100(3): 1191-6. Mukhopadhyay A, Tan EK, Khoo YT, Chan SY, Lim IJ and Phan TT (2005). "Conditioned medium from keloid keratinocyte/keloid fibroblast coculture induces contraction of fibroblast-populated collagen lattices." Br J Dermatol 152(4): 639-45. Naji A, Durrbach A, Carosella ED and Rouas-Freiss N (2007a). "Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T-cell alloproliferation through ILT-2/ILT4/FasL-mediated pathways." Hum Immunol 68(4): 233-9. Naji A, Le Rond S, Durrbach A, Krawice-Radanne I, Creput C, Daouya M, Caumartin J, LeMaoult J, Carosella ED and Rouas-Freiss N (2007b). "CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance." Blood 110(12): 3936-48. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N and Yamanaka S (2008). "Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts." Nat Biotechnol 26(1): 101-6. 193 Nanaev AK, Kohnen G, Milovanov AP, Domogatsky SP and Kaufmann P (1997). "Stromal differentiation and architecture of the human umbilical cord." Placenta 18(1): 53-64. Nasef A, Mathieu N, Chapel A, Frick J, Francois S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D and Fouillard L (2007). "Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G." Transplantation 84(2): 231-7. Natsu K, Ochi M, Mochizuki Y, Hachisuka H, Yanada S and Yasunaga Y (2004). "Allogeneic bone marrow-derived mesenchymal stromal cells promote the regeneration of injured skeletal muscle without differentiation into myofibers." Tissue Eng 10(7-8): 1093-112. Nauta AJ, Kruisselbrink AB, Lurvink E, Willemze R and Fibbe WE (2006). "Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells." J Immunol 177(4): 2080-7. Ng ES, Davis RP, Azzola L, Stanley EG and Elefanty AG (2005). "Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation." Blood 106(5): 1601-3. Nguyen TH, Khakhoulina T, Simmons A, Morel P and Trono D (2005). "A simple and highly effective method for the stable transduction of uncultured porcine hepatocytes using lentiviral vector." Cell Transplant 14(7): 489-96. Okita K, Ichisaka T and Yamanaka S (2007). "Generation of germline-competent induced pluripotent stem cells." Nature 448(7151): 313-7. Okita K, Nakagawa M, Hyenjong H, Ichisaka T and Yamanaka S (2008). "Generation of mouse induced pluripotent stem cells without viral vectors." Science 322(5903): 949-53. Pace JL, Morales PJ, Phillips TA and Hunt JS (2006). "Analysis of the soluble isoforms of HLAG mRNAs and proteins." Methods Mol Med 122: 181-203. Parham P (2004). "NK cells and trophoblasts: partners in pregnancy." J Exp Med 200(8): 951-5. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, Lerou PH, Lensch MW and Daley GQ (2008). "Reprogramming of human somatic cells to pluripotency with defined factors." Nature 451(7175): 141-6. Pepper AR, Gall C, Mazzuca DM, Melling CW and White DJ (2009). "Diabetic rats and mice are resistant to porcine and human insulin: flawed experimental models for testing islet xenografts." Xenotransplantation 16(6): 502-10. Perin L, Giuliani S, Jin D, Sedrakyan S, Carraro G, Habibian R, Warburton D, Atala A and De Filippo RE (2007). "Renal differentiation of amniotic fluid stem cells." Cell Prolif 40(6): 936-48. Pierdomenico L, Bonsi L, Calvitti M, Rondelli D, Arpinati M, Chirumbolo G, Becchetti E, Marchionni C, Alviano F, Fossati V, Staffolani N, Franchina M, Grossi A and Bagnara GP (2005). "Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp." Transplantation 80(6): 836-42. 194 Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR (1999). "Multilineage potential of adult human mesenchymal stem cells." Science 284(5411): 143-7. Plumas J, Chaperot L, Richard MJ, Molens JP, Bensa JC and Favrot MC (2005). "Mesenchymal stem cells induce apoptosis of activated T cells." Leukemia 19(9): 1597-604. Polonsky KS and Rubenstein AH (1984). "C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations." Diabetes 33(5): 486-94. Prevosto C, Zancolli M, Canevali P, Zocchi MR and Poggi A (2007). "Generation of CD4+ or CD8+ regulatory T cells upon mesenchymal stem cell-lymphocyte interaction." Haematologica 92(7): 881-8. Prince HE and John JK (1988). "Flow cytometric analysis of lymphocyte activation in the mixed lymphocyte response." Immunol Invest 17(4): 309-19. Prusa AR, Marton E, Rosner M, Bernaschek G and Hengstschlager M (2003). "Oct-4-expressing cells in human amniotic fluid: a new source for stem cell research?" Hum Reprod 18(7): 1489-93. Qiu J, Terasaki PI, Miller J, Mizutani K, Cai J and Carosella ED (2006). "Soluble HLA-G expression and renal graft acceptance." Am J Transplant 6(9): 2152-6. Rachakatla RS, Marini F, Weiss ML, Tamura M and Troyer D (2007). "Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors." Cancer Gene Ther 14(10): 828-35. Rajagopal J, Anderson WJ, Kume S, Martinez OI and Melton DA (2003). "Insulin staining of ES cell progeny from insulin uptake." Science 299(5605): 363. Rajagopalan S and Long EO (1999). "A human histocompatibility leukocyte antigen (HLA)-Gspecific receptor expressed on all natural killer cells." J Exp Med 189(7): 1093-100. Ramasamy R, Fazekasova H, Lam EW, Soeiro I, Lombardi G and Dazzi F (2007). "Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle." Transplantation 83(1): 71-6. Rambhatla L, Chiu CP, Kundu P, Peng Y and Carpenter MK (2003). "Generation of hepatocytelike cells from human embryonic stem cells." Cell Transplant 12(1): 1-11. Rasmusson I, Le Blanc K, Sundberg B and Ringden O (2007). "Mesenchymal stem cells stimulate antibody secretion in human B cells." Scand J Immunol 65(4): 336-43. Rasmusson I, Ringden O, Sundberg B and Le Blanc K (2003). "Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells." Transplantation 76(8): 1208-13. Rebmann V, LeMaoult J, Rouas-Freiss N, Carosella ED and Grosse-Wilde H (2007). "Quantification and identification of soluble HLA-G isoforms." Tissue Antigens 69 Suppl 1: 143-9. 195 Ren B, O'Brien BA, Swan MA, Koina ME, Nassif N, Wei MQ and Simpson AM (2007). "Longterm correction of diabetes in rats after lentiviral hepatic insulin gene therapy." Diabetologia 50(9): 1910-20. Reubinoff BE, Itsykson P, Turetsky T, Pera MF, Reinhartz E, Itzik A and Ben-Hur T (2001). "Neural progenitors from human embryonic stem cells." Nat Biotechnol 19(12): 1134-40. Reza HM, Ng BY, Gimeno FL, Phan TT and Ang LP (2011). "Umbilical Cord Lining Stem Cells as a Novel and Promising Source for Ocular Surface Regeneration." Stem Cell Rev: epub ahead of print. Reza HM, Ng BY, Phan TT, Tan DT, Beuerman RW and Ang LP (2010). "Characterization of a Novel Umbilical Cord Lining Cell with CD227 Positivity and Unique Pattern of P63 Expression and Function." Stem Cell Rev: epub ahead of print. Ristich V, Liang S, Zhang W, Wu J and Horuzsko A (2005). "Tolerization of dendritic cells by HLA-G." Eur J Immunol 35(4): 1133-42. Riteau B, Menier C, Khalil-Daher I, Sedlik C, Dausset J, Rouas-Freiss N and Carosella ED (1999). "HLA-G inhibits the allogeneic proliferative response." J Reprod Immunol 43(2): 203-11. Rizzo R, Hviid TV, Govoni M, Padovan M, Rubini M, Melchiorri L, Stignani M, Carturan S, Grappa MT, Fotinidi M, Ferretti S, Voss A, Laustrup H, Junker P, Trotta F and Baricordi OR (2008). "HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus." Tissue Antigens 71(6): 520-9. Robertson NJ, Brook FA, Gardner RL, Cobbold SP, Waldmann H and Fairchild PJ (2007). "Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance." Proc Natl Acad Sci U S A 104(52): 20920-5. Romieu-Mourez R, Francois M, Boivin MN, Stagg J and Galipeau J (2007). "Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density." J Immunol 179(3): 1549-58. Roobrouck VD, Ulloa-Montoya F and Verfaillie CM (2008). "Self-renewal and differentiation capacity of young and aged stem cells." Exp Cell Res 314(9): 1937-44. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J and Carosella ED (1997). "Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis." Proc Natl Acad Sci U S A 94(21): 11520-5. Roubelakis MG, Pappa KI, Bitsika V, Zagoura D, Vlahou A, Papadaki HA, Antsaklis A and Anagnou NP (2007). "Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells." Stem Cells Dev 16(6): 931-52. Rozen S and Skaletsky H (2000). "Primer3 on the WWW for general users and for biologist programmers." Methods Mol Biol 132: 365-86. 196 Ruetze M, Gallinat S, Lim IJ, Chow E, Phan TT, Staeb F, Wenck H, Deppert W and Knott A (2008). "Common features of umbilical cord epithelial cells and epidermal keratinocytes." J Dermatol Sci 50(3): 227-31. Saito S (2000). "Cytokine network at the feto-maternal interface." J Reprod Immunol 47(2): 87103. Sakuragawa N, Enosawa S, Ishii T, Thangavel R, Tashiro T, Okuyama T and Suzuki S (2000). "Human amniotic epithelial cells are promising transgene carriers for allogeneic cell transplantation into liver." J Hum Genet 45(3): 171-6. Sakuragawa N, Kakinuma K, Kikuchi A, Okano H, Uchida S, Kamo I, Kobayashi M and Yokoyama Y (2004). "Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells." J Neurosci Res 78(2): 208-14. Sallusto F and Lanzavecchia A (1994). "Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin and downregulated by tumor necrosis factor alpha." J Exp Med 179(4): 1109-18. Sankar V and Muthusamy R (2003). "Role of human amniotic epithelial cell transplantation in spinal cord injury repair research." Neuroscience 118(1): 11-7. Sarugaser R, Lickorish D, Baksh D, Hosseini MM and Davies JE (2005). "Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors." Stem Cells 23(2): 220-9. Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, Muroi K and Ozawa K (2007). "Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells." Blood 109(1): 228-34. Sato Y, Araki H, Kato J, Nakamura K, Kawano Y, Kobune M, Sato T, Miyanishi K, Takayama T, Takahashi M, Takimoto R, Iyama S, Matsunaga T, Ohtani S, Matsuura A, Hamada H and Niitsu Y (2005). "Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion." Blood 106(2): 756-63. Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, RouasFreiss N, Carosella ED and Deschaseaux F (2008). "Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells." Stem Cells 26(1): 212-22. Sessarego N, Parodi A, Podesta M, Benvenuto F, Mogni M, Raviolo V, Lituania M, Kunkl A, Ferlazzo G, Bricarelli FD, Uccelli A and Frassoni F (2008). "Multipotent mesenchymal stromal cells from amniotic fluid: solid perspectives for clinical application." Haematologica 93(3): 339-46. Shaw JE, Sicree RA and Zimmet PZ (2009). "Global estimates of the prevalence of diabetes for 2010 and 2030." Diabetes Res Clin Pract. 197 Sheshgiri R, Rao V, Tumiati LC, Xiao R, Prodger JL, Badiwala M, Librach C and Delgado DH (2008a). "Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells." Circulation 118(14 Suppl): S58-64. Sheshgiri R, Rouas-Freiss N, Rao V, Butany J, Ramzy D, Krawice-Radanne I, Ross HJ, Carosella ED and Delgado DH (2008b). "Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients." J Heart Lung Transplant 27(5): 522-7. Shiroishi M, Tsumoto K, Amano K, Shirakihara Y, Colonna M, Braud VM, Allan DS, Makadzange A, Rowland-Jones S, Willcox B, Jones EY, van der Merwe PA, Kumagai I and Maenaka K (2003). "Human inhibitory receptors Ig-like transcript (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G." Proc Natl Acad Sci U S A 100(15): 8856-61. Shultz LD, Ishikawa F and Greiner DL (2007). "Humanized mice in translational biomedical research." Nat Rev Immunol 7(2): 118-30. Sivalingam J, Krishnan S, Ng WH, Lee SS, Phan TT and Kon OL (2010). "Biosafety assessment of site-directed transgene integration in human umbilical cord-lining cells." Mol Ther 18(7): 1346-56. Smith M, Bittner JGt, White S, Smith D and Horuzsko A (2008). "HLA-G-treated tolerogenic dendritic cells induce tolerogenic potential by increasing expression of B7-1 (CD80) molecules." Transplant Proc 40(5): 1598-603. Solari MG, Srinivasan S, Boumaza I, Unadkat J, Harb G, Garcia-Ocana A and Feili-Hariri M (2009). "Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia." J Autoimmun 32(2): 116-24. Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A, Wengler GS and Parolini O (2007). "Isolation and characterization of mesenchymal cells from human fetal membranes." J Tissue Eng Regen Med 1(4): 296-305. Sotiropoulou PA, Perez SA, Gritzapis AD, Baxevanis CN and Papamichail M (2006). "Interactions between human mesenchymal stem cells and natural killer cells." Stem Cells 24(1): 74-85. Spaggiari GM, Abdelrazik H, Becchetti F and Moretta L (2009). "MSCs inhibit monocytederived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2." Blood 113(26): 6576-83. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC and Moretta L (2008). "Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2." Blood 111(3): 1327-33. Spaggiari GM, Capobianco A, Becchetti S, Mingari MC and Moretta L (2006). "Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation." Blood 107(4): 1484-90. 198 Steiner DF (1998). "The proprotein convertases." Curr Opin Chem Biol 2(1): 31-9. Stolzing A, Jones E, McGonagle D and Scutt A (2008). "Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies." Mech Ageing Dev 129(3): 163-73. Sullivan LC, Clements CS, Rossjohn J and Brooks AG (2008). "The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity." Tissue Antigens 72(5): 415-24. Sumi S, Gu Y, Hiura A and Inoue K (2004). "Stem cells and regenerative medicine for diabetes mellitus." Pancreas 29(3): e85-9. Swijnenburg RJ, Schrepfer S, Govaert JA, Cao F, Ransohoff K, Sheikh AY, Haddad M, Connolly AJ, Davis MM, Robbins RC and Wu JC (2008). "Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts." Proc Natl Acad Sci U S A 105(35): 12991-6. Swijnenburg RJ, Tanaka M, Vogel H, Baker J, Kofidis T, Gunawan F, Lebl DR, Caffarelli AD, de Bruin JL, Fedoseyeva EV and Robbins RC (2005). "Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium." Circulation 112(9 Suppl): I166-72. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K and Yamanaka S (2007). "Induction of pluripotent stem cells from adult human fibroblasts by defined factors." Cell 131(5): 861-72. Takashima S, Ise H, Zhao P, Akaike T and Nikaido T (2004). "Human amniotic epithelial cells possess hepatocyte-like characteristics and functions." Cell Struct Funct 29(3): 73-84. Tamagawa T, Ishiwata I and Saito S (2004). "Establishment and characterization of a pluripotent stem cell line derived from human amniotic membranes and initiation of germ layers in vitro." Hum Cell 17(3): 125-30. Tang KC, Trzaska KA, Smirnov SV, Kotenko SV, Schwander SK, Ellner JJ and Rameshwar P (2008). "Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA." J Immunol 180(3): 1826-33. Tatard VM, D'Ippolito G, Diabira S, Valeyev A, Hackman J, McCarthy M, Bouckenooghe T, Menei P, Montero-Menei CN and Schiller PC (2007). "Neurotrophin-directed differentiation of human adult marrow stromal cells to dopaminergic-like neurons." Bone 40(2): 360-73. Tateishi K, He J, Taranova O, Liang G, D'Alessio AC and Zhang Y (2008). "Generation of insulin-secreting islet-like clusters from human skin fibroblasts." J Biol Chem 283(46): 31601-7. Thomsen M, Yacoub-Youssef H and Marcheix B (2005). "Reconstitution of a human immune system in immunodeficient mice: models of human alloreaction in vivo." Tissue Antigens 66(2): 73-82. 199 Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS and Jones JM (1998). "Embryonic stem cell lines derived from human blastocysts." Science 282(5391): 1145-7. Timper K, Seboek D, Eberhardt M, Linscheid P, Christ-Crain M, Keller U, Muller B and Zulewski H (2006). "Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells." Biochem Biophys Res Commun 341(4): 1135-40. Torricelli F, Brizzi L, Bernabei PA, Gheri G, Di Lollo S, Nutini L, Lisi E, Di Tommaso M and Cariati E (1993). "Identification of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation." Ital J Anat Embryol 98(2): 119-26. Tsai MS, Lee JL, Chang YJ and Hwang SM (2004). "Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol." Hum Reprod 19(6): 1450-6. Tsuji H, Miyoshi S, Ikegami Y, Hida N, Asada H, Togashi I, Suzuki J, Satake M, Nakamizo H, Tanaka M, Mori T, Segawa K, Nishiyama N, Inoue J, Makino H, Miyado K, Ogawa S, Yoshimura Y and Umezawa A (2010). "Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes." Circ Res 106(10): 1613-23. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB and Lansdorp PM (1994). "Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age." Proc Natl Acad Sci U S A 91(21): 9857-60. Verda L, Kim DA, Ikehara S, Statkute L, Bronesky D, Petrenko Y, Oyama Y, He X, Link C, Vahanian NN and Burt RK (2008). "Hematopoietic mixed chimerism derived from allogeneic embryonic stem cells prevents autoimmune diabetes mellitus in NOD mice." Stem Cells 26(2): 381-6. Wang HS, Hung SC, Peng ST, Huang CC, Wei HM, Guo YJ, Fu YS, Lai MC and Chen CC (2004). "Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord." Stem Cells 22(7): 1330-7. Wei JP, Zhang TS, Kawa S, Aizawa T, Ota M, Akaike T, Kato K, Konishi I and Nikaido T (2003). "Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice." Cell Transplant 12(5): 545-52. Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, Troyer D and McIntosh KR (2008). "Immune properties of human umbilical cord Wharton's jellyderived cells." Stem Cells 26(11): 2865-74. Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, Luo Y, Rao MS, Velagaleti G and Troyer D (2006). "Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease." Stem Cells 24(3): 781-92. Wexler SA, Donaldson C, Denning-Kendall P, Rice C, Bradley B and Hows JM (2003). "Adult bone marrow is a rich source of human mesenchymal 'stem' cells but umbilical cord and mobilized adult blood are not." Br J Haematol 121(2): 368-74. 200 Wild S, Roglic G, Green A, Sicree R and King H (2004). "Global prevalence of diabetes: estimates for the year 2000 and projections for 2030." Diabetes Care 27(5): 1047-53. Wolbank S, Peterbauer A, Fahrner M, Hennerbichler S, van Griensven M, Stadler G, Redl H and Gabriel C (2007). "Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue." Tissue Eng 13(6): 1173-83. Xu C, Police S, Rao N and Carpenter MK (2002). "Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells." Circ Res 91(6): 501-8. Yang CC, Shih YH, Ko MH, Hsu SY, Cheng H and Fu YS (2008). "Transplantation of human umbilical mesenchymal stem cells from Wharton's jelly after complete transection of the rat spinal cord." PLoS ONE 3(10): e3336. Yatoh S, Dodge R, Akashi T, Omer A, Sharma A, Weir GC and Bonner-Weir S (2007). "Differentiation of affinity-purified human pancreatic duct cells to beta-cells." Diabetes 56(7): 1802-9. Yie SM, Taylor RN and Librach C (2005). "Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy." Am J Obstet Gynecol 193(1): 204-8. Yie SM, Yang H, Ye SR, Li K, Dong DD and Lin XM (2007). "Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma." Ann Surg Oncol 14(10): 2721-9. Zalzman M, Anker-Kitai L and Efrat S (2005). "Differentiation of human liver-derived, insulinproducing cells toward the beta-cell phenotype." Diabetes 54(9): 2568-75. Zappia E, Casazza S, Pedemonte E, Benvenuto F, Bonanni I, Gerdoni E, Giunti D, Ceravolo A, Cazzanti F, Frassoni F, Mancardi G and Uccelli A (2005). "Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy." Blood 106(5): 1755-61. Zhang HT, Fan J, Cai YQ, Zhao SJ, Xue S, Lin JH, Jiang XD and Xu RX (2010). "Human Wharton's jelly cells can be induced to differentiate into growth factor-secreting oligodendrocyte progenitor-like cells." Differentiation 79(1): 15-20. Zhang SC, Wernig M, Duncan ID, Brustle O and Thomson JA (2001). "In vitro differentiation of transplantable neural precursors from human embryonic stem cells." Nat Biotechnol 19(12): 1129-33. Zhou Q, Brown J, Kanarek A, Rajagopal J and Melton DA (2008a). "In vivo reprogramming of adult pancreatic exocrine cells to beta-cells." Nature 455(7213): 627-32. Zhou S, Greenberger JS, Epperly MW, Goff JP, Adler C, Leboff MS and Glowacki J (2008b). "Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts." Aging Cell 7(3): 335-43. 201 Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P and Hedrick MH (2002). "Human adipose tissue is a source of multipotent stem cells." Mol Biol Cell 13(12): 4279-95. 202 [...]... 2 Immunological studies of human umbilical cord derived stem cells Zhou Y, Phan T T, Gan S U, Calne R, Lee K O and MacAry P A (2006) Abstract presented at National Healthcare Group (NHG) Annual Scientific Congress 2006 3 Analyzing the immunogenicity of human umbilical cord lining derived stem cells Zhou Y, Phan T T, Gan S U, Calne R, Lee K O and MacAry P A (2006) Abstract presented at World Transplant... sequences for HLA-G gene silencing…………………………… 56   xvii   xviii LIST OF PUBLICATION AND PRESENTATIONS 1 Characterization of human umbilical cord lining derived epithelial cells and transplantation potential Zhou Y, Gan S U, Lin G, Lim Y T, Masilamani J, Mustafa F, Phua M L, Rivino L, Phan T T, Lee K O, Calne R, MacAry P A Accepted 12/30/2010 for publication in “Cell Transplantation”, epub ahead of print 03/24/2011... SUMMARY This study describes the immunological characterization of a novel primary epithelial cell-type from the human umbilical cord Two types of cells can be derived from the umbilical cord lining membrane, termed cord lining epithelial cells (CLECs) and cord lining mesenchymal cells (CLMCs) Preliminary immunophenotyping showed that CLECs but not CLMCs express significant levels of HLA-G isoforms and. .. major cause of premature illness and death in most countries, mainly through the increased risk of cardiovascular disease Other complications such as chronic nephropathy, retinal damage and neuropathy, lead to conditions as severe as kidney failure, blindness and limb amputation The frequency of diabetes is rising dramatically all over the world and has been recognized as a global epidemic In 2000, according... molecular marker expressions including the immunosuppressive molecules HLA-G and HLA-E 6 2 To study the immunological properties of cord lining cells using in vitro assays of T lymphocyte activation and dendritic cell maturation 3 To investigate the mechanisms of cord lining cell and T lymphocyte interactions 4 To study the immunogenicity of cord lining cells in vivo using an immunocompetent mouse model. .. organs/tissues and extreme shortage in their supply Additionally, cell transplantation has the versatility with ease of ex vivo culture and manipulation, potentially incorporating gene therapy into the transplantation approach Hence, novel strategies of using cell therapy and/ or gene therapy for the treatment of diabetes are being studied intensively For the treatment of type 1 diabetes, the areas of cell therapy... S U, Calne R, Lee K O and MacAry P A (2007) Oral presentation at 13th congress of the European Society for Organ Transplantation (ESOT)   xix   xx LIST of ABBREVIATIONS ABSL animal biosafety level AEC amniotic epithelial cell AF amniotic fluid AFSC amniotic fluid stem cell AHU animal holding unit AMC amniotic mesenchymal cell APC allophycocyanin balb bagg albino BLAST basic local alignment search tool... therapies Transplantation of isolated islets has also been used as an alternative to whole pancreas transplantation, which involves much less invasive surgical procedures However, both pancreatic and islet transplantations are limited by the lack of suitable donor organs/tissues The relatively new discipline of cell transplantation has the potential to fill the gap between increasing need of donor organs/tissues... success has been reported mainly with multipotent mesenchymal stem cells (MSCs) MSCs derived from bone marrow (Gabr et al 2008), Wharton’s jelly (Chao et al 2008) and adipose tissues (Chandra et al 2009) have been differentiated into insulin producing clusters Successful applications of those MSC -derived insulinproducing cells in treatment of diabetic animals have also been reported Problems that remain... hyperglycemia and is sometimes required in the treatment of type 2 diabetes as well However, patterns of physiologic insulin release are very hard to mimic with injections of exogenous insulin Even with the use of insulin premixes and analogs and close glucose monitoring, the risks of postprandial 1 hyperglycemia and hypoglycemia are present and long-term complications may still develop 1.1.2 Pancreas and .  i IMMUNOLOGICAL CHARACTERIZATION OF HUMAN UMBILICAL CORD LINING DERIVED CELLS AND THEIR THERAPEUTIC APPLICATION IN A DIABETIC MOUSE MODEL ZHOU YUE A THESIS SUBMITTED.  xviii  xix LIST OF PUBLICATION AND PRESENTATIONS 1. Characterization of human umbilical cord lining derived epithelial cells and transplantation potential. Zhou Y, Gan S U, Lin G, Lim Y T, Masilamani. CLECs has been tested in the treatment of a type 1 diabetes mouse model.  xv LIST OF FIGURES AND TABLES Figure 3.1 Schematic of human umbilical cord and the isolation of cord lining cells